Emmanuelle Charpentier of the Max Planck Institute for Infection Biology in Germany and Jennifer Doudna of the University of California, Berkeley, USA, the developers of the CRISPR-Cas9 genome editing technology, have been awarded the Nobel Prize in Chemistry 2020.
Based on the license to use CRISPR-Cas9, we developed tomatoes with high GABA contents, a functional component that can suppress blood pressure rise.
(Please refer to “History of Selective Breeding and the Significance of Genome Editing Today” for more details on the mechanism of genome editing technology and our product.)
In October 2019, the notification system for the distribution of genome-edited crops has been established in Japan.
We are working to submit a notification to sell the first genome-edited crop in Japan and committed to leading the promotion of social acceptance for the genome-edited crops by our products globally.
Here, “Sana” in the company name means “health” in Latin, and we hope that it will make people healthier with our products.
So we will do our best to bring our tomatoes to you as early as possible.